Institutional Ownership Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD). We have compiled data on the 55 institutions that hold shares in the stock, with a total of 5.43 Million shares, which have been reported (via 13F filing form) to have a value of $6.09 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Front Row Advisors LLC
Tiburon, CA |
Aug 15, 2025 Q2 2025 |
3
shares
|
$4
0.0% of portfolio
|
Q2 2025
Reduced 50.0%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
2
shares
|
$2
0.0% of portfolio
|
Q1 2025
Reduced 100.0%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1
shares
|
$1
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
1
shares
|
$1
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|